Healthcare provider profile · identity verified

Seth Coombs, MD

Family Practice · LOVINGTON, NM · NPI 1801388822

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	280	50
Atorvastatin Calcium	Atorvastatin Calcium	213	59
Omeprazole	Omeprazole	198	58
Gabapentin	Gabapentin	171	49
Eliquis	Apixaban	169	18
Furosemide	Furosemide	167	44
Metoprolol Succinate	Metoprolol Succinate	162	39
Amlodipine Besylate	Amlodipine Besylate	158	55
Lisinopril	Lisinopril	155	51
Potassium Chloride	Potassium Chloride	144	43
Trazodone Hcl	Trazodone Hcl	137	40
Losartan Potassium	Losartan Potassium	130	34
Metformin Hcl	Metformin Hcl	126	35
Hydrochlorothiazide	Hydrochlorothiazide	115	40
Tamsulosin Hcl	Tamsulosin Hcl	114	39
Irbesartan	Irbesartan	89	33
Famotidine	Famotidine	88	24
Diclofenac Sodium	Diclofenac Sodium	86	35
Albuterol Sulfate Hfa	Albuterol Sulfate	80	21
Meloxicam	Meloxicam	78	30
Pravastatin Sodium	Pravastatin Sodium	70	21
Hydroxyzine Hcl	Hydroxyzine Hcl	69	15
Carvedilol	Carvedilol	68	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	16
Fluticasone Propionate	Fluticasone Propionate	64	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	19
Rosuvastatin Calcium	Rosuvastatin Calcium	61	22
Simvastatin	Simvastatin	60	22
Mounjaro	Tirzepatide	56	11
Ibuprofen	Ibuprofen	54	25
Mirtazapine	Mirtazapine	53	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	53	17
Donepezil Hcl	Donepezil Hcl	51	16
Buspirone Hcl	Buspirone Hcl	49	14
Methocarbamol	Methocarbamol	48	17
Clopidogrel	Clopidogrel Bisulfate	47	14
Duloxetine Hcl	Duloxetine Hcl	45	11
Escitalopram Oxalate	Escitalopram Oxalate	45	suppressed
Metformin Hcl Er	Metformin Hcl	45	15
Ozempic	Semaglutide	44	suppressed
Alendronate Sodium	Alendronate Sodium	42	13
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	12
Jardiance	Empagliflozin	40	suppressed
Glipizide	Glipizide	39	suppressed
Montelukast Sodium	Montelukast Sodium	38	12
Sertraline Hcl	Sertraline Hcl	38	11
Trulicity	Dulaglutide	38	suppressed
Pregabalin	Pregabalin	37	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	36	16
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	11
Spironolactone	Spironolactone	33	suppressed
Azelastine Hcl	Azelastine Hcl	32	suppressed
Baclofen	Baclofen	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	suppressed
Alprazolam	Alprazolam	30	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Novolog Flexpen	Insulin Aspart	29	suppressed
Divalproex Sodium	Divalproex Sodium	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	11
Allopurinol	Allopurinol	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Multaq	Dronedarone Hcl	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	22
Xarelto	Rivaroxaban	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Finasteride	Finasteride	24	suppressed
Cephalexin	Cephalexin	23	14
Benazepril Hcl	Benazepril Hcl	22	suppressed
Bumetanide	Bumetanide	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Prednisone	Prednisone	21	13
Lactulose	Lactulose	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Estradiol	Estradiol	19	suppressed
Naproxen	Naproxen	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Ramipril	Ramipril	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Naproxen Sodium	Naproxen Sodium	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Armour Thyroid	Thyroid,pork	15	suppressed
Atenolol	Atenolol	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Clozapine	Clozapine	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Clozapine Odt	Clozapine	11	suppressed
Demeclocycline Hcl	Demeclocycline Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Symtuza	Darunavir/Cob/Emtri/Tenof Alaf	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error